279 related articles for article (PubMed ID: 21305279)
1. An altered camelid-like single domain anti-idiotypic antibody fragment of HM-1 killer toxin: acts as an effective antifungal agent.
Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
Appl Microbiol Biotechnol; 2011 Apr; 90(2):553-64. PubMed ID: 21305279
[TBL] [Abstract][Full Text] [Related]
2. Cloning antifungal single chain fragment variable antibodies by phage display and competitive panning elution.
Krishnaswamy S; Kabir ME; Miyamoto M; Furuichi Y; Komiyama T
Anal Biochem; 2009 Dec; 395(1):16-24. PubMed ID: 19665444
[TBL] [Abstract][Full Text] [Related]
3. Different buffer effects in selecting HM-1 killer toxin single-chain fragment variable anti-idiotypic antibodies.
Krishnaswamy S; Kabir ME; Miyamoto M; Furuichi Y; Komiyama T
J Biochem; 2010 May; 147(5):723-33. PubMed ID: 20097900
[TBL] [Abstract][Full Text] [Related]
4. New avenues for phage-display library to produce a Cryptococcus-specific anti-idiotypic antibody of HM-1 killer toxin.
Rahman MM; Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
J Mol Recognit; 2011; 24(4):631-41. PubMed ID: 21584874
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of recombinant single chain fragment variable anti-idiotypic antibody specific to Aspergillus fumigatus membrane protein.
Krishnaswamy S; Kabir ME; Rahman MM; Miyamoto M; Furuichi Y; Komiyama T
J Immunol Methods; 2011 Mar; 366(1-2):60-8. PubMed ID: 21277307
[TBL] [Abstract][Full Text] [Related]
6. Peptide derived from anti-idiotypic single-chain antibody is a potent antifungal agent compared to its parent fungicide HM-1 killer toxin peptide.
Kabir ME; Karim N; Krishnaswamy S; Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
Appl Microbiol Biotechnol; 2011 Dec; 92(6):1151-60. PubMed ID: 21691785
[TBL] [Abstract][Full Text] [Related]
7. An improved phage-display panning method to produce an HM-1 killer toxin anti-idiotypic antibody.
Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
BMC Biotechnol; 2009 Dec; 9():99. PubMed ID: 20003392
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.
Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
Antimicrob Agents Chemother; 2006 Sep; 50(9):3090-7. PubMed ID: 16940106
[TBL] [Abstract][Full Text] [Related]
9. Purification and functional characterization of a Camelid-like single-domain antimycotic antibody by engineering in affinity tag.
Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
Protein Expr Purif; 2010 Jul; 72(1):59-65. PubMed ID: 20060473
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of beta-1,3-glucan synthase and cell growth of Cryptococcus species by recombinant single-chain anti-idiotypic antibodies.
Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
J Antibiot (Tokyo); 2006 Feb; 59(2):73-9. PubMed ID: 16629406
[TBL] [Abstract][Full Text] [Related]
11. Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.
Juárez-González VR; Riaño-Umbarila L; Quintero-Hernández V; Olamendi-Portugal T; Ortiz-León M; Ortíz E; Possani LD; Becerril B
J Mol Biol; 2005 Mar; 346(5):1287-97. PubMed ID: 15713481
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a neutralizing monoclonal antibody for the epitope on HM-1 killer toxin.
Selvakumar D; Zhang QZ; Miyamoto M; Furuichi Y; Komiyama T
J Biochem; 2006 Mar; 139(3):399-406. PubMed ID: 16567405
[TBL] [Abstract][Full Text] [Related]
13. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.
Manfredi M; McCullough MJ; Conti S; Polonelli L; Vescovi P; Al-Karaawi ZM; Porter SR
Oral Microbiol Immunol; 2005 Aug; 20(4):226-32. PubMed ID: 15943767
[TBL] [Abstract][Full Text] [Related]
15. [Construction and screening of human anti-idiotypic single chain antibodies of nasopharyngeal carcinoma].
He XJ; Li GC; Zhu JG; Li YH; Zhou GH
Ai Zheng; 2004 Feb; 23(2):124-9. PubMed ID: 14960228
[TBL] [Abstract][Full Text] [Related]
16. Thermodynamics and kinetics of the reaction of a single-chain antibody fragment (scFv) with the leucine zipper domain of transcription factor GCN4.
Weber-Bornhauser S; Eggenberger J; Jelesarov I; Bernard A; Berger C; Bosshard HR
Biochemistry; 1998 Sep; 37(37):13011-20. PubMed ID: 9737882
[TBL] [Abstract][Full Text] [Related]
17. From yeast killer toxins to antibiobodies and beyond.
Magliani W; Conti S; Travassos LR; Polonelli L
FEMS Microbiol Lett; 2008 Nov; 288(1):1-8. PubMed ID: 18785931
[TBL] [Abstract][Full Text] [Related]
18. [Production of phage-displayed anti-idiotypic antibody single chain variable fragments to MG7 monoclonal antibody directed against gastric carcinoma].
He F; Nie Y; Han Z
Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):33-6. PubMed ID: 11798849
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.
Magliani W; Conti S; de Bernardis F; Gerloni M; Bertolotti D; Mozzoni P; Cassone A; Polonelli L
Nat Biotechnol; 1997 Feb; 15(2):155-8. PubMed ID: 9035141
[TBL] [Abstract][Full Text] [Related]
20. A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold.
Desiderio A; Franconi R; Lopez M; Villani ME; Viti F; Chiaraluce R; Consalvi V; Neri D; Benvenuto E
J Mol Biol; 2001 Jul; 310(3):603-15. PubMed ID: 11439027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
